glp-1 monitoring tools for home use Weekly Injection Tracker: Medication & Weight Loss Log (PDF) Introducing GLP-1 Insights - The

In the meantime, well continue to fight for patients every single day: helping ensure continuity of care for those already on GLP-1s and enabling new patients to start the most effective treatment available.

Several mid-stage trials will read out in 2025 to provide important proof points for novel MoAs and their potential for differentiation, e.g., Lillys bimagrumab (activin/myostatin type II receptor inhibitor) in combination with semaglutide, aiming to deliver weight loss while preserving muscle mass (phase 2b)

, Schwartz, T

February 2026

Throughout this article, we have explored various aspects of semaglutide, a medication primarily used to manage diabetes and support weight loss